Terms: = Leukemia AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790
881 results:
1. Measurable residual disease monitoring by ddPCR in the early posttransplant period complements the traditional MFC method to predict relapse after HSCT in AML/MDS: a multicenter retrospective study.
Chen W; Huang J; Zhao Y; Huang L; Yuan Z; Gu M; Xu X; Shi J; Luo Y; Yu J; Lai X; Liu L; Fu H; Bao C; Huang X; Zheng Z; Huang H; Hu X; Zhao Y
J Transl Med; 2024 Apr; 22(1):410. PubMed ID: 38689269
[TBL] [Abstract] [Full Text] [Related]
2. Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients.
Borsi E; Vigliotta I; Poletti A; Mazzocchetti G; Solli V; Zazzeroni L; Martello M; Armuzzi S; Taurisano B; Kanapari A; Pistis I; Zamagni E; Pantani L; Rocchi S; Mancuso K; Tacchetti P; Rizzello I; Rizzi S; Dan E; Sinigaglia B; Cavo M; Terragna C
Cells; 2024 Apr; 13(8):. PubMed ID: 38667272
[TBL] [Abstract] [Full Text] [Related]
3. [Gene Profile and Clinical Significance of Concomitant Mutations in CN-AML Patients with
Zhu J; Kang YF; Gao Y; Wang HW; Hao ZH; Wang HW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):335-341. PubMed ID: 38660833
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical Characteristics and Prognosis of Acute Myeloid leukemia Patients with
Shan RQ; Huang S; Gu ZY; Wang N; Liu DH; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):327-334. PubMed ID: 38660832
[TBL] [Abstract] [Full Text] [Related]
5. A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias.
Mavridou E; Lema Fernandez AG; Nardelli C; Pierini V; Quintini M; Arniani S; Di Giacomo D; Crescenzi B; Matteucci C; Sambani C; Mecucci C
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23235. PubMed ID: 38656651
[TBL] [Abstract] [Full Text] [Related]
6. Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line.
Demirkiran N; Aydin B; Pehlivan M; Yuce Z; Sercan HO
Med Oncol; 2024 Apr; 41(5):109. PubMed ID: 38592567
[TBL] [Abstract] [Full Text] [Related]
7. Natural history of clonal haematopoiesis seen in real-world haematology settings.
Patel SA; Gerber WK; Zheng R; Khanna S; Hutchinson L; Abel GA; Cerny J; DaSilva BA; Zhang TY; Ramanathan M; Khedr S; Selove W; Woda B; Miron PM; Higgins AW; Gerber JM
Br J Haematol; 2024 May; 204(5):1844-1855. PubMed ID: 38522849
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
Iat A; Loschi M; Benachour S; Calleja A; Chiche E; Sudaka I; Aquaronne D; Ferrero C; Fenwarth L; Marceau A; Fournier E; Dadone-Montaudie B; Cluzeau T
Cancer Med; 2024 Mar; 13(6):e7103. PubMed ID: 38506267
[TBL] [Abstract] [Full Text] [Related]
9. Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
Chien KS; Ong F; Kim K; Li Z; Kanagal-Shamanna R; DiNardo CD; Takahashi K; Montalban-Bravo G; Hammond D; Sasaki K; Pierce SA; Kantarjian HM; Garcia-Manero G
Cancer Med; 2024 Mar; 13(5):e7093. PubMed ID: 38497538
[TBL] [Abstract] [Full Text] [Related]
10. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
Patnaik MM; Tefferi A
Am J Hematol; 2024 Jun; 99(6):1142-1165. PubMed ID: 38450850
[TBL] [Abstract] [Full Text] [Related]
11. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Mata DA; Lee JK; Shanmugam V; Marcus CB; Schrock AB; Williams EA; Ritterhouse LL; Hickman RA; Janovitz T; Patel NR; Kroger BR; Ross JS; Mirza KM; Oxnard GR; Vergilio JA; Elvin JA; Benhamida JK; Decker B; Xu ML
Histopathology; 2024 Jun; 84(7):1224-1237. PubMed ID: 38422618
[TBL] [Abstract] [Full Text] [Related]
12. The crossroads of cancer therapies and clonal hematopoiesis.
Singh A; Balasubramanian S
Semin Hematol; 2024 Feb; 61(1):16-21. PubMed ID: 38403501
[TBL] [Abstract] [Full Text] [Related]
13. Mechanisms of action and resistance in histone methylation-targeted therapy.
Yamagishi M; Kuze Y; Kobayashi S; Nakashima M; Morishima S; Kawamata T; Makiyama J; Suzuki K; Seki M; Abe K; Imamura K; Watanabe E; Tsuchiya K; Yasumatsu I; Takayama G; Hizukuri Y; Ito K; Taira Y; Nannya Y; Tojo A; Watanabe T; Tsutsumi S; Suzuki Y; Uchimaru K
Nature; 2024 Mar; 627(8002):221-228. PubMed ID: 38383791
[TBL] [Abstract] [Full Text] [Related]
14. tet2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database.
Pan X; Chang Y; Ruan G; Zhou S; Jiang H; Jiang Q; Huang X; Zhao XS
Clin Exp Med; 2024 Feb; 24(1):35. PubMed ID: 38349460
[TBL] [Abstract] [Full Text] [Related]
15. The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus.
Xu F; Jin J; Guo J; Xu F; Chen J; Liu Q; Song L; Zhang Z; Zhou L; Su J; Xiao C; Zhang Y; Yan M; He Q; Wu D; Chang C; Li X; Wu L
J Cancer Res Clin Oncol; 2024 Feb; 150(2):71. PubMed ID: 38305890
[TBL] [Abstract] [Full Text] [Related]
16. Nonpreferential but Detrimental Accumulation of Macrophages With Clonal Hematopoiesis-Driver Mutations in Cardiovascular Tissues-Brief Report.
Dederichs TS; Yerdenova A; Horstmann H; Vico TA; Nübling S; Peyronnet R; Pfeifer D; von Zur Muehlen C; Heidt T; Wolf D; Czerny M; Westermann D; Hilgendorf I
Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):690-697. PubMed ID: 38269586
[TBL] [Abstract] [Full Text] [Related]
17. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Tefferi A; Vannucchi AM; Barbui T
Am J Hematol; 2024 Apr; 99(4):697-718. PubMed ID: 38269572
[TBL] [Abstract] [Full Text] [Related]
18. Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.
Dunbar AJ; Bowman RL; Park YC; O'Connor K; Izzo F; Myers RM; Karzai A; Zaroogian Z; Kim WJ; Fernández-Maestre I; Waarts MR; Nazir A; Xiao W; Codilupi T; Brodsky M; Farina M; Cai L; Cai SF; Wang B; An W; Yang JL; Mowla S; Eisman SE; Hanasoge Somasundara AV; Glass JL; Mishra T; Houston R; Guzzardi E; Martinez Benitez AR; Viny AD; Koche RP; Meyer SC; Landau DA; Levine RL
Cancer Discov; 2024 May; 14(5):737-751. PubMed ID: 38230747
[TBL] [Abstract] [Full Text] [Related]
19. Increased iron uptake by splenic hematopoietic stem cells promotes tet2-dependent erythroid regeneration.
Tseng YJ; Kageyama Y; Murdaugh RL; Kitano A; Kim JH; Hoegenauer KA; Tiessen J; Smith MH; Uryu H; Takahashi K; Martin JF; Samee MAH; Nakada D
Nat Commun; 2024 Jan; 15(1):538. PubMed ID: 38225226
[TBL] [Abstract] [Full Text] [Related]
20. Recurrent Aortic Thromboembolism Associated With
Bukhari S; Saati A; Abuhalimeh B; Ouma G
J Investig Med High Impact Case Rep; 2024; 12():23247096231224366. PubMed ID: 38214069
[TBL] [Abstract] [Full Text] [Related]
[Next]
